Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Winston

Showing results (251-260 of 373) with videos related to

Pageof 38
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2023
Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With ValganciclovirGenovefa A Papanicolaou, Robin K Avery, Catherine Cordonnier, et al.
Microorganisms|August 26, 2023
Transient SARS-CoV-2 RNA-Dependent RNA Polymerase Mutations after Remdesivir Treatment for Chronic COVID-19 in Two Transplant Recipients: Case Report and Intra-Host Viral Genomic InvestigationShangxin Yang, Ashrit Multani, Jacob M Garrigues, et al.
The New England Journal of Medicine|January 26, 2007
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropeniaOliver A Cornely, Johan Maertens, Drew J Winston, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 21, 2022
Spasticity Management Teams, Evaluations, and Tools: A Canadian Cross-Sectional SurveyPatricia B Mills, Chetan P Phadke, Chris Boulias, et al.
The New England Journal of Medicine|September 10, 1981
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemiaR G Strauss, J E Connett, R P Gale, et al.
Current Alzheimer Research|August 20, 2013
CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo-Controlled StudyJ Ross, S Sharma, J Winston, et al.
Transplantation|May 16, 2014
Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic featuresDrew J Winston, Holenarasipur R Vikram, Ingrid B Rabe, et al.
Blood|February 21, 2008
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging studyDrew J Winston, Jo-Anne H Young, Vinod Pullarkat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2024
AURORA: A New DawnGenovefa A Papanicolaou, Robin K Avery, Catherine Cordonnier, et al.
Open Forum Infectious Diseases|July 16, 2020
Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic CancerMichael J Boeckh, Ann M Arvin, Kathleen M Mullane, et al.
Pageof 38

Showing results (251-260 of 373) with videos related to

Sort By:
Pageof 38
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2023
Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With ValganciclovirGenovefa A Papanicolaou, Robin K Avery, Catherine Cordonnier, et al.
Microorganisms|August 26, 2023
Transient SARS-CoV-2 RNA-Dependent RNA Polymerase Mutations after Remdesivir Treatment for Chronic COVID-19 in Two Transplant Recipients: Case Report and Intra-Host Viral Genomic InvestigationShangxin Yang, Ashrit Multani, Jacob M Garrigues, et al.
The New England Journal of Medicine|January 26, 2007
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropeniaOliver A Cornely, Johan Maertens, Drew J Winston, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 21, 2022
Spasticity Management Teams, Evaluations, and Tools: A Canadian Cross-Sectional SurveyPatricia B Mills, Chetan P Phadke, Chris Boulias, et al.
The New England Journal of Medicine|September 10, 1981
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemiaR G Strauss, J E Connett, R P Gale, et al.
Current Alzheimer Research|August 20, 2013
CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo-Controlled StudyJ Ross, S Sharma, J Winston, et al.
Transplantation|May 16, 2014
Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic featuresDrew J Winston, Holenarasipur R Vikram, Ingrid B Rabe, et al.
Blood|February 21, 2008
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging studyDrew J Winston, Jo-Anne H Young, Vinod Pullarkat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2024
AURORA: A New DawnGenovefa A Papanicolaou, Robin K Avery, Catherine Cordonnier, et al.
Open Forum Infectious Diseases|July 16, 2020
Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic CancerMichael J Boeckh, Ann M Arvin, Kathleen M Mullane, et al.
Pageof 38